Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Apogee Therapeutics Inc. (APGE) had Weighted-Average Shares Outstanding (Diluted) of 58.43M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-66.10M |
|
-- |
|
-- |
|
$73.17M |
|
$-73.17M |
|
$7.14M |
|
$-66.02M |
|
$-66.02M |
|
$-66.10M |
|
$-66.10M |
|
$-66.10M |
|
$-66.10M |
|
$-73.17M |
|
$-74.53M |
|
58.43M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
58.43M |
$-1.13 |
|
$-1.13 |
|
| Balance Sheet Financials | |
$516.12M |
|
$6.44M |
|
$141.65M |
|
$657.77M |
|
$31.55M |
|
-- |
|
$6.82M |
|
$38.37M |
|
$619.40M |
|
$619.40M |
|
$619.40M |
|
58.56M |
|
| Cash Flow Statement Financials | |
$-110.51M |
|
$91.11M |
|
$1.80M |
|
$142.08M |
|
$124.49M |
|
$-17.60M |
|
$22.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-115.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.67% |
|
-10.67% |
|
-10.05% |
|
-10.67% |
|
$10.58 |
|
$-1.98 |
|
$-1.89 |
|